The market has been high on Quest Diagnostics Inc (DGX) stock recently. DGX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.
Quest Diagnostics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on DGX!
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With DGX Stock Today?
Quest Diagnostics Inc (DGX) stock is lower by -0.82% while the S&P 500 has gained 0.49% as of 3:21 PM on Friday, Dec 1. DGX is lower by -$1.12 from the previous closing price of $137.23 on volume of 610,999 shares. Over the past year the S&P 500 is up 12.51% while DGX is lower by -10.35%. DGX earned $6.67 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.42.
To screen for more stocks like Quest Diagnostics Inc click here.
More About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Click Here to get the full Stock Report for Quest Diagnostics Inc stock.